Lung ischemia-reperfusion injury: A molecular and clinical view on a complex pathophysiological process

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 5, 2010, Pages

  Den Hengst, Willem A ^a   Gielis, Jan F ^a   Lin, Judy Y ^b   Van Schil, Paul E ^a   De Windt, Leon J ^b   Moens, An L ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Lung transplantation; Pulmonary; Ventilated ischemia

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ALLOPURINOL; APOCYNIN; CASPASE; CHEMOKINE; CYCLOSPORIN A; CYTOKINE; DIPHENYLIODONIUM SALT; ESTRADIOL; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; OXIPURINOL; PROSTAGLANDIN E1; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; SURFACTANT; TACROLIMUS; THROMBOCYTE ACTIVATING FACTOR; TRANSCRIPTION FACTOR AP 1; XANTHINE; XANTHINE OXIDASE;

CELL DEATH; CELL PROTECTION; DRUG MECHANISM; ENZYME INHIBITION; GENE THERAPY; HUMAN; ISCHEMIA; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG ISCHEMIA; MITOCHONDRION; NEUTROPHIL; NONHUMAN; ORGAN PRESERVATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; CARDIOPULMONARY BYPASS; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MODELS, ANIMAL; REGIONAL BLOOD FLOW; REPERFUSION INJURY;

EID: 78249253648     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00251.2010     Document Type: Review

References (213)

1. Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M. A key role for TRPM7 channels in anoxic neuronal death. Cell 115: 863-877, 2003. (Pubitemid 38058498)
2. Abe A, Hiraoka M, Wild S, Wilcoxen SE, Paine R III, Shayman JA. Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J Biol Chem 279: 42605-42611, 2004. (Pubitemid 39372145)
3. Abraham D, Taghavi S, Riml P, Paulus P, Hofmann M, Baumann C, Kocher A, Klepetko W, Aharinejad S. VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 73: 1703-1706, 2002. (Pubitemid 34655243)
4. Adkins WK, Taylor AE. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J Appl Physiol 69: 2012-2018, 1990.
5. al-Mehdi AB, Shuman H, Fisher AB. Intracellular generation of reactive oxygen species during nonhypoxic lung ischemia. Am J Physiol Lung Cell Mol Physiol 272: L294-L300, 1997.
6. al-Mehdi AB, Zhao G, Dodia C, Tozawa K, Costa K, Muzykantov V, Ross C, Blecha F, Dinauer M, Fisher AB. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 83: 730-737, 1998.
7. al-Mehdi AB, Zhao G, Fisher AB. ATP-independent membrane depolarization with ischemia in the oxygen-ventilated isolated rat lung. Am J Respir Cell Mol Biol 18: 653-661, 1998.
8. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA, Ware LB. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161: 1783-1796, 2002. (Pubitemid 35265536)
9. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 199: 8-17, 2003. (Pubitemid 36061187)
10. Allen SP, Darley-Usmar VM, McCormack JG, Stone D. Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation. J Mol Cell Cardiol 25: 949-958, 1993. (Pubitemid 23317722)
11. Allison RC, Kyle J, Adkins WK, Prasad VR, McCord JM, Taylor AE. Effect of ischemia reperfusion or hypoxia reoxygenation on lung vascular permeability and resistance. J Appl Physiol 69: 597-603, 1990.
12. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138: S69-S75, 1999.
13. Aoe M, Trachiotis GD, Okabayashi K, Manchester JK, Lowry OH, Cooper JD, Patterson GA. Administration of prostaglandin E1 after lung transplantation improves early graft function. Ann Thorac Surg 58: 655-661, 1994.
14. Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargaftig BB, Bereziat G, Voelker DR, Wolf C, Touqui L. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 102: 1152-1160, 1998.
15. Armstead VE, Minchenko AG, Schuhl RA, Hayward R, Nossuli TO, Lefer AM. Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am J Physiol Heart Circ Physiol 273: H740-H746, 1997.
16. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A 91: 10089-10093, 1994.
17. Axon RN, Baird MS, Lang JD, Brix AE, Nielsen VG. PentaLyte decreases lung injury after aortic occlusion-reperfusion. Am J Respir Crit Care Med 157: 1982-1990, 1998.
18. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 87: 13-20, 1996.
19. Barillari G, Albonici L, Incerpi S, Bogetto L, Pistritto G, Volpi A, Ensoli B, Manzari V. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function. Atherosclerosis 154: 377-385, 2001.
20. Beere HM. "The stress of dying": the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117: 2641-2651, 2004.
21. Bellido-Reyes YA, Akamatsu H, Kojima K, Arai H, Tanaka H, Sunamori M. Cytosolic phospholipase A2 inhibition attenuates ischemia-reperfusion injury in an isolated rat lung model. Transplantation 81: 1700-1707, 2006.
22. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98: 13681-13686, 2001.
23. Bhabra MS, Hopkinson DN, Shaw TE, Hooper TL. Attenuation of lung graft reperfusion injury by a nitric oxide donor. J Thorac Cardiovasc Surg 113: 327-333, 1997.
24. Bittner HB, Binner C, Dahlberg P, Mohr FW. Reducing ischemia-reperfusion injury in clinical lung transplantation. Transplant Proc 39: 489-492, 2007.
25. Bogoyevitch MA, Arthur PG. Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim Biophys Acta 1784: 76-93, 2008.
26. Borutaite V, Jekabsone A, Morkuniene R, Brown GC. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J Mol Cell Cardiol 35: 357-366, 2003.
27. Boscoe MJ, Goodwin AT, Amrani M, Yacoub MH. Endothelins and the lung. Int J Biochem Cell Biol 32: 41-62, 2000.
28. Boyle EM Jr, Canty TG Jr, Morgan EN, Yun W, Pohlman TH, Verrier ED. Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription. Ann Thorac Surg 68: 1949-1953, 1999.
29. Brady HR. Leukocyte adhesion molecules and kidney diseases. Kidney Int 45: 1285-1300, 1994.
30. 2+ release. Free Radic Biol Med 29: 343-348, 2000.
31. Brookes PS. Mitochondrial nitric oxide synthase. Mitochondrion 3: 187-204, 2004.
32. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287: C817-C833, 2004.
33. Buccellato LJ, Tso M, Akinci OI, Chandel NS, Budinger GR. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J Biol Chem 279: 6753-6760, 2004.
34. Cassivi SD, Cardella JA, Fischer S, Liu M, Slutsky AS, Keshavjee S. Transtracheal gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation. J Heart Lung Transplant 18: 1181-1188, 1999.
35. Chang DM, Hsu K, Ding YA, Chiang CH. Interleukin-1 in ischemiareperfusion acute lung injury. Am J Respir Crit Care Med 156: 1230-1234, 1997.
36. Chapman JT, Otterbein LE, Elias JA, Choi AM. Carbon monoxide attenuates aeroallergen-induced inflammation in mice. Am J Physiol Lung Cell Mol Physiol 281: L209-L216, 2001.
37. Chen Q, Camara AK, Stowe DF, Hoppel CL, Lesnefsky EJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol 292: C137-C147, 2007.
38. Chen Q, Lesnefsky EJ. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med 40: 976-982, 2006.
39. Chiang CH, Pai HI, Liu SL. Ventilator-induced lung injury (VILI) promotes ischemia/reperfusion lung injury (I/R) and NF-kappaB antibody attenuates both injuries. Resuscitation 79: 147-154, 2008.
40. Chiu JJ, Wung BS, Shyy JY, Hsieh HJ, Wang DL. Reactive oxygen species are involved in shear stress-induced intercellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 17: 3570-3577, 1997.
41. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24: 1454-1459, 2005.
42. Clark SC. Lung injury after cardiopulmonary bypass. Perfusion 21: 225-228, 2006.
43. Clayton CE, Carraway MS, Suliman HB, Thalmann ED, Thalmann KN, Schmechel DE, Piantadosi CA. Inhaled carbon monoxide and hyperoxic lung injury in rats. Am J Physiol Lung Cell Mol Physiol 281: L949-L957, 2001.
44. Cobelens PM, van Putte BP, Kavelaars A, Heijnen CJ, Kesecioglu J. Inflammatory consequences of lung ischemia-reperfusion injury and low-pressure ventilation. J Surg Res 153: 295-301, 2009.
45. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 116: 205-219, 2004.
46. De Leyn P, Flameng W, Lerut T. Pattern of AMP degradation in ischemic rabbit lung tissue. J Invest Surg 8: 7-19, 1995.
47. de Perrot M, Fischer S, Liu M, Jin R, Bai XH, Waddell TK, Keshavjee S. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. Transplantation 72: 1505-1512, 2001.
48. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167: 490-511, 2003.
49. de Perrot M, Sekine Y, Fischer S, Waddell TK, McRae K, Liu M, Wigle DA, Keshavjee S. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165: 211-215, 2002.
50. Dedkova EN, Blatter LA. Characteristics and function of cardiac mitochondrial nitric oxide synthase. J Physiol 587: 851-872, 2009.
51. Dinauer MC. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. Crit Rev Clin Lab Sci 30: 329-369, 1993.
52. Dodd O, Pearse DB. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 279: H303-H312, 2000.
53. Dodd-o JM, Welsh LE, Salazar JD, Walinsky PL, Peck EA, Shake JG, Caparrelli DJ, Ziegelstein RC, Zweier JL, Baumgartner WA, Pearse DB. Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury. Am J Physiol Heart Circ Physiol 287: H927-H936, 2004.
54. Dolinay T, Szilasi M, Liu M, Choi AM. Inhaled carbon monoxide confers antiinflammatory effects against ventilator-induced lung injury. Am J Respir Crit Care Med 170: 613-620, 2004.
55. Dreyer N, Muhlfeld C, Fehrenbach A, Pech T, von Berg S, Nagib R, Richter J, Wittwer T, Wahlers T, Ochs M. Exogenous surfactant application in a rat lung ischemia reperfusion injury model: effects on edema formation and alveolar type II cells. Respir Res 9: 5, 2008.
56. Ege T, Arar C, Canbaz S, Cikirikcioglu M, Sunar H, Yuksel V, Duran E. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 52: 10-15, 2004.
57. Ellis JA, Mayer SJ, Jones OT. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J 251: 887-891, 1988.
58. Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 150: 1773-1784, 1997.
59. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Ward PA. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res 58: 713-718, 1995.
60. Esme H, Fidan H, Koken T, Solak O. Effect of lung ischemia-reperfusion on oxidative stress parameters of remote tissues. Eur J Cardiothorac Surg 29: 294-298, 2006.
61. Farivar AS, Delgado MF, McCourtie AS, Barnes AD, Verrier ED, Mulligan MS. Crosstalk between thrombosis and inflammation in lung reperfusion injury. Ann Thorac Surg 81: 1061-1067, 2006.
62. Featherstone RL, Chambers DJ, Kelly FJ. Ischemic preconditioning enhances recovery of isolated rat lungs after hypothermic preservation. Ann Thorac Surg 69: 237-242, 2000.
63. Feletou M, Lonchampt M, Coge F, Galizzi JP, Bassoullet C, Merial C, Robineau P, Boutin JA, Huang PL, Vanhoutte PM, Canet E. Regulation of murine airway responsiveness by endothelial nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 281: L258-L267, 2001.
64. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 274: 2225-2233, 1999.
65. Fischer S, Cassivi SD, Xavier AM, Cardella JA, Cutz E, Edwards V, Liu M, Keshavjee S. Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. Ann Surg 231: 424-431, 2000.
66. Fischer S, Liu M, MacLean AA, de Perrot M, Ho M, Cardella JA, Zhang XM, Bai XH, Suga M, Imai Y, Keshavjee S. In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Hum Gene Ther 12: 1513-1526, 2001.
67. Fischer S, MacLean AA, Liu M, Cardella JA, Slutsky AS, Suga M, Moreira JF, Keshavjee S. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 162: 1932-1939, 2000.
68. Fisher AB. Reactive oxygen species and cell signaling with lung ischemia. Undersea Hyperb Med 31: 97-103, 2004.
69. Fisher AB, al-Mehdi AB, Manevich Y. Shear stress and endothelial cell activation. Crit Care Med 30: S192-S197, 2002.
70. Fisher AB, Dodia C, Tan ZT, Ayene I, Eckenhoff RG. Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest 88: 674-679, 1991.
71. Fisher AJ, Donnelly SC, Hirani N, Haslett C, Strieter RM, Dark JH, Corris PA. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 163: 259-265, 2001.
72. Friedrich I, Spillner J, Lu EX, Bartling B, Barnscheid M, Sablotzki A, Schade U, Reidemeister JC, Silber RE, Gunther A, Borgermann J. Ischemic pre-conditioning of 5 min but not of 10 minutes improves lung function after warm ischemia in a canine model. J Heart Lung Transplant 20: 985-995, 2001. (Pubitemid 32824145)
73. Ghafourifar P, Schenk U, Klein SD, Richter C. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem 274: 31185-31188, 1999. (Pubitemid 129501564)
74. Gilmont RR, Dardano A, Engle JS, Adamson BS, Welsh MJ, Li T, Remick DG, Smith DJ Jr, Rees RS. TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. J Surg Res 61: 175-182, 1996. (Pubitemid 26066048)
75. Girgis RE, Li D, Zhan X, Garcia JG, Tuder RM, Hassoun PM, Johns RA. Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol 285: H938-H945, 2003. (Pubitemid 37048146)
76. Goto T, Ishizaka A, Kobayashi F, Kohno M, Sawafuji M, Tasaka S, Ikeda E, Okada Y, Maruyama I, Kobayashi K. Importance of tumor necrosis factor-alpha cleavage process in post-transplantation lung injury in rats. Am J Respir Crit Care Med 170: 1239-1246, 2004.
77. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A 92: 7809-7813, 1995.
78. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 174: 167-172, 1997.
79. Halestrap AP, Griffiths EJ, Connern CP. Mitochondrial calcium handling and oxidative stress. Biochem Soc Trans 21: 353-358, 1993.
80. Hart CM. Nitric oxide in adult lung disease. Chest 115: 1407-1417, 1999.
81. Hearse DJ, Maxwell L, Saldanha C, Gavin JB. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol 25: 759-800, 1993.
82. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
83. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 11: 955-964, 1997.
84. Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 17: 525-531, 1998.
85. Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, Wang DL. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol 175: 156-162, 1998.
86. Ishii M, Suzuki Y, Takeshita K, Miyao N, Kudo H, Hiraoka R, Nishio K, Sato N, Naoki K, Aoki T, Yamaguchi K. Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 172: 2569-2577, 2004.
87. Ishiyama T, Dharmarajan S, Hayama M, Moriya H, Grapperhaus K, Patterson GA. Inhibition of nuclear factor kappaB by IkappaB suppressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 130: 194-201, 2005.
88. Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, Yoshikawa T, Kitamura N. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Eur J Cardiothorac Surg 25: 530-536, 2004.
89. Jalali S, Li YS, Sotoudeh M, Yuan S, Li S, Chien S, Shyy JY. Shear stress activates p60src-Ras-MAPK signaling pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 18: 227-234, 1998. (Pubitemid 28277599)
90. Javadpour M, Kelly CJ, Chen G, Stokes K, Leahy A, Bouchier-Hayes DJ. Thermotolerance induces heat shock protein 72 expression and protects against ischaemia-reperfusion-induced lung injury. Br J Surg 85: 943-946, 1998.
91. 2 tension difference after bilateral lung transplantation. Crit Care Med 21: 1035-1040, 1993.
92. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998.
93. Jurmann MJ, Dammenhayn L, Schaefers HJ, Haverich A. Pulmonary reperfusion injury: evidence for oxygen-derived free radical mediated damage and effects of different free radical scavengers. Eur J Cardiothorac Surg 4: 665-670, 1990.
94. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim Biophys Acta 1604: 77-94, 2003.
95. Kaifu K, Kiyomoto H, Hitomi H, Matsubara K, Hara T, Moriwaki K, Ihara G, Fujita Y, Sugasawa N, Nagata D, Nishiyama A, Kohno M. Insulin attenuates apoptosis induced by high glucose via the PI3-kinase/Akt pathway in rat peritoneal mesothelial cells. Nephrol Dial Transplant 24: 809-815, 2009.
96. Kaminski A, Kasch C, Zhang L, Kumar S, Sponholz C, Choi YH, Ma N, Liebold A, Ladilov Y, Steinhoff G, Stamm C. Endothelial nitric oxide synthase mediates protective effects of hypoxic preconditioning in lungs. Respir Physiol Neurobiol 155: 280-285, 2007.
97. Kaminski A, Pohl CB, Sponholz C, Ma N, Stamm C, Vollmar B, Steinhoff G. Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. Am J Pathol 164: 2241-2249, 2004.
98. Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Bland KI, Chaudry IH. Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G. Ann Surg 248: 294-302, 2008.
99. Karimova A, Pinsky DJ. The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med 27: 19-31, 2001.
100. Keenan RJ, Griffith BP, Kormos RL, Armitage JM, Hardesty RL. Increased perioperative lung preservation injury with lung procurement by Euro-Collins solution flush. J Heart Lung Transplant 10: 650-655, 1991.
101. Kennedy TP, Rao NV, Hopkins C, Pennington L, Tolley E, Hoidal JR. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest 83: 1326-1335, 1989.
102. Kermeen FD, McNeil KD, Fraser JF, McCarthy J, Ziegenfuss MD, Mullany D, Dunning J, Hopkins PM. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant 26: 850-856, 2007.
103. Keshavjee S, Davis RD, Zamora MR, de Perrot M, Patterson GA. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg 129: 423-428, 2005.
104. Keshavjee SH, Yamazaki F, Cardoso PF, McRitchie DI, Patterson GA, Cooper JD. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg 98: 529-534, 1989.
105. Khimenko PL, Bagby GJ, Fuseler J, Taylor AE. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol 85: 2005-2011, 1998.
106. Khimenko PL, Moore TM, Wilson PS, Taylor AE. Role of calmodulin and myosin light-chain kinase in lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 271: L121-L125, 1996.
107. Kinnula VL, Sarnesto A, Heikkila L, Toivonen H, Mattila S, Raivio KO. Assessment of xanthine oxidase in human lung and lung transplantation. Eur Respir J 10: 676-680, 1997.
108. Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 1792: 941-953, 2009.
109. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1508, 1974.
110. Koksoy C, Kuzu MA, Ergun H, Demirpence E, Zulfikaroglu B. Intestinal ischemia and reperfusion impairs vasomotor functions of pulmonary vascular bed. Ann Surg 231: 105-111, 2000.
111. Krishnadasan B, Naidu B, Rosengart M, Farr AL, Barnes A, Verrier ED, Mulligan MS. Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg 123: 756-767, 2002.
112. Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 125: 261-272, 2003. (Pubitemid 36228304)
113. Kuhnle GE, Reichenspurner H, Lange T, Wagner F, Groh J, Messmer K, Goetz AE. Microhemodynamics and leukocyte sequestration after pulmonary ischemia and reperfusion in rabbits. J Thorac Cardiovasc Surg 115: 937-944, 1998.
114. Kuratani T, Matsuda H, Sawa Y, Kaneko M, Nakano S, Kawashima Y. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg 103: 564-568, 1992.
115. Kuwano K, Hara N. Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. Am J Respir Cell Mol Biol 22: 147-149, 2000.
116. Lan Q, Mercurius KO, Davies PF. Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress. Biochem Biophys Res Commun 201: 950-956, 1994.
117. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 11: 118-124, 1997.
118. Lansman JB. Endothelial mechanosensors. Going with the flow. Nature 331: 481-482, 1988.
119. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516-8525, 2003.
120. Lockinger A, Schutte H, Walmrath D, Seeger W, Grimminger F. Protection against gas exchange abnormalities by pre-aerosolized PGE1, iloprost and nitroprusside in lung ischemia-reperfusion. Transplantation 71: 185-193, 2001.
121. Lu HL, Chiang CH. Combined therapy of pentastarch, dexamethasone, and dibutyryl-cAMP or beta 2-agonist attenuates ischaemia/reperfusion injury of rat lung. Injury 39: 1062-1070, 2008.
122. Luh SP, Kuo PH, Kuo TF, Tsai TP, Tsao TC, Chen JY, Tsai CH, Yang PC. Effects of thermal preconditioning on the ischemia-reperfusion-induced acute lung injury in minipigs. Shock 28: 615-622, 2007.
123. Lynch MJ, Grum CM, Gallagher KP, Bolling SF, Deeb GM, Morganroth ML. Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injury. J Surg Res 44: 538-544, 1988.
124. Maccherini M, Keshavjee SH, Slutsky AS, Patterson GA, Edelson JD. The effect of low-potassium-dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 52: 621-626, 1991.
125. Majno G, Joris I. Apoptosis, oncosis, necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.
126. Marczin N. The biology of exhaled nitric oxide (NO) in ischemia-reperfusion-induced lung injury: a tale of dynamism of NO production and consumption. Vascul Pharmacol 43: 415-424, 2005.
127. Martin TR, Nakamura M, Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med 31: S184-S188, 2003. (Pubitemid 36458165)
128. Matthay MA, Fukuda N, Frank J, Kallet R, Daniel B, Sakuma T. Alveolar epithelial barrier. Role in lung fluid balance in clinical lung injury. Clin Chest Med 21: 477-490, 2000.
129. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-L399, 2008.
130. Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS, Christman JW, Schlondorff D, Seeger W, Lohmeyer J. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol 170: 3273-3278, 2003.
131. Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE. Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic saline-dextran reinfusion. Circ Shock 31: 407-418, 1990.
132. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
133. Miotla JM, Jeffery PK, Hellewell PG. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am J Respir Cell Mol Biol 18: 197-204, 1998.
134. Mizutani H, Minamoto K, Aoe M, Yamashita M, Date H, Andou A, Shimizu N. Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in a canine lung transplantation model. J Heart Lung Transplant 17: 835-845, 1998.
135. Moens AL, Champion HC, Claeys MJ, Tavazzi B, Kaminski PM, Wolin MS, Borgonjon DJ, Van NL, Haile A, Zviman M, Bedja D, Wuyts FL, Elsaesser RS, Cos P, Gabrielson KL, Lazzarino G, Paolocci N, Timmermans JP, Vrints CJ, Kass DA. High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 117: 1810-1819, 2008.
136. Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26: 2439-2444, 2006.
137. Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK, Mitchell JB, Biswal S, Channon KM, Wolin MS, Alp NJ, Paolocci N, Champion HC, Kass DA. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117: 2626-2636, 2008.
138. Moore TM, Khimenko P, Adkins WK, Miyasaka M, Taylor AE. Adhesion molecules contribute to ischemia and reperfusion-induced injury in the isolated rat lung. J Appl Physiol 78: 2245-2252, 1995.
139. Moore TM, Khimenko PL, Wilson PS, Taylor AE. Role of nitric oxide in lung ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol 271: H1970-H1977, 1996.
140. Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 77: 1507-1518, 1994.
141. Moriwaki Y, Yamamoto T, Yamaguchi K, Takahashi S, Higashino K. Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies. Histochem Cell Biol 105: 71-79, 1996.
142. Morris CR, Morris SM Jr, Hagar W, Van WJ, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 168: 63-69, 2003.
143. Morse D, Choi AM. Heme oxygenase-1: from bench to bedside. Am J Respir Crit Care Med 172: 660-670, 2005.
144. 2+ concentration during shear stress- and agonist-induced vasodilation. Am J Physiol Heart Circ Physiol 276: H1706-H1714, 1999.
145. Murata T, Kinoshita K, Hori M, Kuwahara M, Tsubone H, Karaki H, Ozaki H. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol 25: 2335-2342, 2005.
146. Naidu BV, Fraga C, Salzman AL, Szabo C, Verrier ED, Mulligan MS. Critical role of reactive nitrogen species in lung ischemia-reperfusion injury. J Heart Lung Transplant 22: 784-793, 2003. (Pubitemid 36842931)
147. Naidu BV, Krishnadasan B, Byrne K, Farr AL, Rosengart M, Verrier ED, Mulligan MS. Regulation of chemokine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation. Ann Thorac Surg 74: 899-905, 2002.
148. Naidu BV, Krishnadasan B, Farivar AS, Woolley SM, Thomas R, Van Rooijen N, Verrier ED, Mulligan MS. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 126: 200-207, 2003.
149. Ng CS, Wan S, Arifi AA, Yim AP. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 36: 205-214, 2006.
150. Ng CS, Wan S, Yim AP. Pulmonary ischaemia-reperfusion injury: role of apoptosis. Eur Respir J 25: 356-363, 2005.
151. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest 121: 1269-1277, 2002.
152. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 62: 302-314, 1996.
153. Novick RJ, MacDonald J, Veldhuizen RA, Wan F, Duplan J, Denning L, Possmayer F, Gilpin AA, Yao LJ, Bjarneson D, Lewis JF. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 154: 98-104, 1996. (Pubitemid 26255773)
154. Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, Okubo T. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 160: 3031-3037, 1998.
155. 2+ transient-independent mechanism. Studies in human neutrophils challenged with platelet-activating factor and other receptor agonists. J Biol Chem 265: 21619-21623, 1990.
156. Okada M, Yamashita C, Okada M, Okada K. Contribution of endothelin-1 to warm ischemia/reperfusion injury of the rat lung. Am J Respir Crit Care Med 152: 2105-2110, 1995.
157. Okada Y, Marchevsky AM, Kass RM, Matloff JM, Jordan SC. A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation. Transplantation 66: 1132-1136, 1998.
158. Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279: L1029-L1037, 2000.
159. Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AM. Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol 99: 2423-2432, 2005.
160. Ovechkin AV, Lominadze D, Sedoris KC, Robinson TW, Tyagi SC, Roberts AM. Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 113: 1-12, 2007. (Pubitemid 46825684)
161. Palace GP, Del Vecchio PJ, Horgan MJ, Malik AB. Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis 147: 143-147, 1993. (Pubitemid 23025930)
162. Palace GP, Horgan MJ, Malik AB. Generation of 5-lipoxygenase metabolites following pulmonary reperfusion in isolated rabbit lungs. Prostaglandins 43: 339-349, 1992.
163. Palazzo R, Hamvas A, Shuman T, Kaiser L, Cooper J, Schuster DP. Injury in nonischemic lung after unilateral pulmonary ischemia with reperfusion. J Appl Physiol 72: 612-620, 1992.
164. Parihar MS, Nazarewicz RR, Kincaid E, Bringold U, Ghafourifar P. Association of mitochondrial nitric oxide synthase activity with respiratory chain complex I. Biochem Biophys Res Commun 366: 23-28, 2008. (Pubitemid 50008460)
165. Qayumi AK, English JE, Duncan S, Ansley DM, Pearson B, Nikbakht-Sangari M, Sammartino C, Fradet G. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1. J Heart Lung Transplant 16: 946-955, 1997. (Pubitemid 27408740)
166. Qayumi AK, Jamieson WR, Godin DV, Lam S, Ko KM, Germann E, Van den Broek J. Response to allopurinol pretreatment in a swine model of heart-lung transplantation. J Invest Surg 3: 331-340, 1990.
167. Qiu W, Gu H, Zheng L, Zhou J, Chen D, Chen Y. Pretreatment with edaravone reduces lung mitochondrial damage in an infant rabbit ischemia-reperfusion model. J Pediatr Surg 43: 2053-2060, 2008.
168. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 105: 656-662, 2002.
169. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82, 1998. (Pubitemid 28079218)
170. Rizzo V, McIntosh DP, Oh P, Schnitzer JE. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem 273: 34724-34729, 1998. (Pubitemid 29028162)
171. Ross SD, Kron IL, Gangemi JJ, Shockey KS, Stoler M, Kern JA, Tribble CG, Laubach VE. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol 279: L528-L536, 2000.
172. Ross SD, Tribble CG, Gaughen JR Jr, Shockey KS, Parrino PE, Kron IL. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg 67: 1428-1433, 1999. (Pubitemid 29320250)
173. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861-2874, 2004.
174. Sage E, Mercier O, Van den Eyden F, de Perrot M, Barlier-Mur AM, Dartevelle P, Eddahibi S, Herve P, Fadel E. Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery. Respir Res 9: 19, 2008.
175. Saldias F, Lecuona E, Friedman E, Barnard ML, Ridge KM, Sznajder JI. Modulation of lung liquid clearance by isoproterenol in rat lungs. Am J Physiol Lung Cell Mol Physiol 274: L694-L701, 1998.
176. Sanderson TH, Kumar R, Murariu-Dobrin AC, Page AB, Krause GS, Sullivan JM. Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia. Neurol Res 31: 947-958, 2009.
177. Sarady JK, Zuckerbraun BS, Bilban M, Wagner O, Usheva A, Liu F, Ifedigbo E, Zamora R, Choi AM, Otterbein LE. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J 18: 854-856, 2004.
178. Sato Y, Hogg JC, English D, van Eeden SF. Endothelin-1 changes polymorphonuclear leukocytes' deformability and CD11b expression and promotes their retention in the lung. Am J Respir Cell Mol Biol 23: 404-410, 2000.
179. Scarabelli TM, Stephanou A, Pasini E, Comini L, Raddino R, Knight RA, Latchman DS. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res 90: 745-748, 2002.
180. Schmid RA, Hillinger S, Walter R, Zollinger A, Stammberger U, Speich R, Schaffner A, Weder W, Schoedon G. The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 118: 726-732, 1999.
181. Schutte H, Witzenrath M, Mayer K, Rosseau S, Seeger W, Grimminger F. Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation 72: 1363-1370, 2001.
182. Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, Star RA. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol 13: 167-174, 1995.
183. Shaw MJ, Shennib H, Bousette N, Ohlstein EH, Giaid A. Effect of endothelin receptor antagonist on lung allograft apoptosis and NOSII expression. Ann Thorac Surg 72: 386-390, 2001.
184. Sherman TS, Chen Z, Yuhanna IS, Lau KS, Margraf LR, Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol Lung Cell Mol Physiol 276: L383-L390, 1999.
185. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M, Shimpo H. Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 82: 2017-2023, 2006.
186. Shimizu N, Kita T, Aoe M, Nakata M, Miyai Y, Teramoto S. Changes in levels of arachidonic acid metabolites in blood and bronchoalveolar lavage fluid after warm ischemia-reperfusion of lung. Acta Med Okayama 45: 417-422, 1991.
187. Shoji T, Omasa M, Nakamura T, Yoshimura T, Yoshida H, Ikeyama K, Fukuse T, Wada H. Mild hypothermia ameliorates lung ischemia reperfusion injury in an ex vivo rat lung model. Eur Surg Res 37: 348-353, 2005.
188. Sievers HH, Freund-Kaas C, Eleftheriadis S, Fischer T, Kuppe H, Kraatz EG, Bechtel JF. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg 74: 1167-1172, 2002.
189. Stammberger U, Carboni GL, Hillinger S, Schneiter D, Weder W, Schmid RA. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury. J Heart Lung Transplant 18: 862-868, 1999.
190. Stammberger U, Gaspert A, Hillinger S, Vogt P, Odermatt B, Weder W, Schmid RA. Apoptosis induced by ischemia and reperfusion in experimental lung transplantation. Ann Thorac Surg 69: 1532-1536, 2000.
191. Struber M, Hirt SW, Cremer J, Harringer W, Haverich A. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25: 862-864, 1999.
192. Su CF, Liu DD, Kao SJ, Chen HI. Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion. Eur Respir J 30: 199-204, 2007.
193. Sud N, Sharma S, Wiseman DA, Harmon C, Kumar S, Venema RC, Fineman JR, Black SM. Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 293: L1444-L1453, 2007.
194. Suda T, D'Ovidio F, Daddi N, Ritter JH, Mohanakumar T, Patterson GA. Recipient intramuscular gene transfer of active transforming growth factor-beta1 attenuates acute lung rejection. Ann Thorac Surg 71: 1651-1656, 2001.
195. Suda T, Mora BN, D'Ovidio F, Cooper JA, Hiratsuka M, Zhang W, Mohanakumar T, Patterson GA. In vivo adenovirus-mediated endothelial nitric oxide synthase gene transfer ameliorates lung allograft ischemia-reperfusion injury. J Thorac Cardiovasc Surg 119: 297-304, 2000.
196. Sunose Y, Takeyoshi I, Tsutsumi H, Kawata K, Tokumine M, Iwazaki S, Tomizawa N, Ohwada S, Matsumoto K, Morishita Y. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. J Surg Res 95: 167-173, 2001.
197. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 22: 269-285, 1997.
198. Thabut G, Brugiere O, Leseche G, Stern JB, Fradj K, Herve P, Jebrak G, Marty J, Fournier M, Mal H. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation. Transplantation 71: 1295-1300, 2001.
199. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344, 2003.
200. von Wichert P. Studies on the metabolism of ischemic rabbit lungs. Conclusions for lung transplantation. J Thorac Cardiovasc Surg 63: 285-291, 1972.
201. Wickersham NE, Johnson JJ, Meyrick BO, Gilroy RJ, Loyd JE. Lung ischemia-reperfusion injury in awake sheep: protection with verapamil. J Appl Physiol 71: 1554-1562, 1991.
202. Wittwer T, Grote M, Oppelt P, Franke U, Schaefers HJ, Wahlers T. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation. J Heart Lung Transplant 20: 358-363, 2001.
203. Wolf M, Drubbel V, Hendriks JM, Van Schil PE. Red blood cell accumulation in a rat model of pulmonary ischemia/reperfusion injury. J Cardiovasc Surg (Torino) 50: 351-356, 2009.
204. Yamashita H, Akamine S, Sumida Y, Inoue M, Sawada T, Nagayasu T, Oka T. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. Ann Thorac Surg 78: 292-297, 2004.
205. Yamashita M, Schmid RA, Ando K, Cooper JD, Patterson GA. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg 62: 791-796, 1996.
206. Yano M, Hiratsuka M, Mora BN, Scheule RK, Patterson GA. Transfection of pulmonary artery segments in lung isografts during storage. Ann Thorac Surg 68: 1810-1814, 1999.
207. ATP channel dependent. Am J Physiol Lung Cell Mol Physiol 289: L954-L961, 2005.
208. Zhang SX, Miller JJ, Gozal D, Wang Y. Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function. J Appl Physiol 96: 392-397, 2004.
209. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA, Lee PJ. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. J Biol Chem 278: 22061-22070, 2003.
210. Zhang X, Shan P, Alam J, Fu XY, Lee PJ. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 280: 8714-8721, 2005.
211. Zhao G, al-Mehdi AB, Fisher AB. Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol Lung Cell Mol Physiol 273: L1112-L1117, 1997.
212. Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, Kron IL, Laubach VE. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 291: L1018-L1026, 2006.
213. Zhu C, Bilali A, Georgieva GS, Kurata S, Mitaka C, Imai T. Salvage of nonischemic control lung from injury by unilateral ischemic lung with apocynin, a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, in isolated perfused rat lung. Transl Res 152: 273-282, 2008.